157 related articles for article (PubMed ID: 32008071)
21. CSF B--lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis.
Ljøstad U; Mygland A
J Neurol; 2008 May; 255(5):732-7. PubMed ID: 18344056
[TBL] [Abstract][Full Text] [Related]
22. Pediatric Lyme Neuroborreliosis: Different clinical presentations of the same agent; Single center experience.
Celik T; Celik U; Kömür M; Tolunay O; Yildizdas RD; Yagci-Kupeli B; Kücük F; Eroglu İ
Neuro Endocrinol Lett; 2016; 37(2):107-13. PubMed ID: 27179572
[TBL] [Abstract][Full Text] [Related]
23. [Lyme disease--a reason for sudden sensorineural hearing loss and vestibular neuronitis?].
Walther LE; Hentschel H; Oehme A; Gudziol H; Beleites E
Laryngorhinootologie; 2003 Apr; 82(4):249-57. PubMed ID: 12717599
[TBL] [Abstract][Full Text] [Related]
24. Antibodies to decorin-binding protein B (DbpB) in the diagnosis of Lyme neuroborreliosis in children.
Sillanpää H; Skogman BH; Sarvas H; Seppälä IJ; Lahdenne P
Int J Infect Dis; 2014 Nov; 28():160-3. PubMed ID: 25316329
[TBL] [Abstract][Full Text] [Related]
25. Cerebrospinal fluid findings in adults with acute Lyme neuroborreliosis.
Djukic M; Schmidt-Samoa C; Lange P; Spreer A; Neubieser K; Eiffert H; Nau R; Schmidt H
J Neurol; 2012 Apr; 259(4):630-6. PubMed ID: 21898139
[TBL] [Abstract][Full Text] [Related]
26. Cerebrospinal Fluid B-lymphocyte Chemoattractant CXCL13 in the Diagnosis of Acute Lyme Neuroborreliosis in Children.
Barstad B; Tveitnes D; Noraas S; Selvik Ask I; Saeed M; Bosse F; Vigemyr G; Huber I; Øymar K
Pediatr Infect Dis J; 2017 Dec; 36(12):e286-e292. PubMed ID: 28661964
[TBL] [Abstract][Full Text] [Related]
27. Serodiagnosis of Lyme borreliosis-is IgM in serum more harmful than helpful?
Hillerdal H; Henningsson AJ
Eur J Clin Microbiol Infect Dis; 2021 Jun; 40(6):1161-1168. PubMed ID: 33409833
[TBL] [Abstract][Full Text] [Related]
28. No correlation between symptom duration and intrathecal production of IgM and/or IgG antibodies in Lyme neuroborreliosis - a retrospective cohort study in Denmark.
Krogen I; Skarphédinsson S; Jensen TG; Knudtzen FC
J Infect; 2022 Nov; 85(5):507-512. PubMed ID: 36122734
[TBL] [Abstract][Full Text] [Related]
29. Cerebrospinal fluid CXCL13 as a diagnostic marker of neuroborreliosis in children: a retrospective case-control study.
Remy MM; Schöbi N; Kottanattu L; Pfister S; Duppenthaler A; Suter-Riniker F
J Neuroinflammation; 2017 Aug; 14(1):173. PubMed ID: 28859668
[TBL] [Abstract][Full Text] [Related]
30. Lyme neuroborreliosis in adults: A nationwide prospective cohort study.
Nordberg CL; Bodilsen J; Knudtzen FC; Storgaard M; Brandt C; Wiese L; Hansen BR; Andersen ÅB; Nielsen H; Lebech AM;
Ticks Tick Borne Dis; 2020 Jul; 11(4):101411. PubMed ID: 32178995
[TBL] [Abstract][Full Text] [Related]
31. The predictive value of CXCL13 in suspected Lyme neuroborreliosis: a retrospective cross-sectional study.
Knudtzen FC; Nilsson AC; Hovius JW; Skarphedinsson S
Eur J Clin Microbiol Infect Dis; 2020 Aug; 39(8):1461-1470. PubMed ID: 32172371
[TBL] [Abstract][Full Text] [Related]
32. Comparative Analysis of the Euroimmun CXCL13 Enzyme-Linked Immunosorbent Assay and the ReaScan Lateral Flow Immunoassay for Diagnosis of Lyme Neuroborreliosis.
Ziegler K; Rath A; Schoerner C; Meyer R; Bertsch T; Erbguth F; Bogdan C; Steinmann J; Held J
J Clin Microbiol; 2020 Aug; 58(9):. PubMed ID: 32434781
[TBL] [Abstract][Full Text] [Related]
33. Sensitivity and specificity of a commercial C6 peptide enzyme immuno assay in diagnosis of acute Lyme neuroborreliosis.
Skarpaas T; Ljøstad U; Søbye M; Mygland A
Eur J Clin Microbiol Infect Dis; 2007 Sep; 26(9):675-7. PubMed ID: 17605055
[TBL] [Abstract][Full Text] [Related]
34. IgM and IgG significant reactivity to Borrelia burgdorferi sensu stricto, Borrelia garinii and Borrelia afzelii among Italian patients affected by Lyme arthritis or neuroborreliosis.
Cinco M; Murgia R; Ruscio M; Andriolo B
FEMS Immunol Med Microbiol; 1996 Jun; 14(2-3):159-66. PubMed ID: 8809552
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic performance of cerebrospinal fluid free light chains in Lyme neuroborreliosis - a pilot study.
Tjernberg I; Johansson M; Henningsson AJ
Clin Chem Lab Med; 2019 Nov; 57(12):2008-2018. PubMed ID: 31199760
[TBL] [Abstract][Full Text] [Related]
36. [Clinical manifestation of Lyme borreliosis in children with positive and negatiwe western blot results].
Ołdak E; Rozkiewicz D; Sulik A
Przegl Epidemiol; 2008; 62 Suppl 1():77-82. PubMed ID: 22320039
[TBL] [Abstract][Full Text] [Related]
37. Comparison of immunofluorescence assay (IFA) and LIAISON in patients with different clinical manifestations of Lyme borreliosis.
Cerar T; Ruzic-Sabljic E; Cimperman J; Strle F
Wien Klin Wochenschr; 2006 Nov; 118(21-22):686-90. PubMed ID: 17160608
[TBL] [Abstract][Full Text] [Related]
38. Characteristics and Clinical Outcome of Lyme Neuroborreliosis in a High Endemic Area, 1995-2014: A Retrospective Cohort Study in Denmark.
Knudtzen FC; Andersen NS; Jensen TG; Skarphédinsson S
Clin Infect Dis; 2017 Oct; 65(9):1489-1495. PubMed ID: 29048514
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of two assays for CXCL13 analysis in cerebrospinal fluid for laboratory diagnosis of Lyme neuroborreliosis.
Henningsson AJ; Gyllemark P; Lager M; Skogman BH; Tjernberg I
APMIS; 2016 Nov; 124(11):985-990. PubMed ID: 27651242
[TBL] [Abstract][Full Text] [Related]
40. The Usefulness of Two CXCL13 Assays on Cerebrospinal Fluid for the Diagnosis of Lyme Neuroborreliosis: a Retrospective Study in a Routine Clinical Setting.
van Gorkom T; van Arkel GHJ; Heron M; Voet W; Thijsen SFT; Kremer K
J Clin Microbiol; 2021 Aug; 59(9):e0025521. PubMed ID: 34132584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
